Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



Chr Hansen eyes pharma sector with €20m probiotic plant expansion

By Shane Starling , 19-Feb-2013

Chr Hansen eyes pharma sector with €20m probiotic plant expansion

Global probiotics leader Chr Hansen is throwing €20m at the expansion of its Danish freeze-drying capacity with increasing global pharma  and food supplement demand the key driver.

“We are turning the production facility in Roskilde, Denmark, into a dedicated production site for human health products, both to live up to pharma GMPs and to free capacity at our food culture production site in Avedoere/Copenhagen,” spokesperson Ulrik Raabjerg Soendergaard told us.

“Yes, the demand for probiotics with pharma GMP [good manufacturing practices] approval is increasing.”

The new facility is slated to open in the first half of 2014, will be fully pharma-grade compliant and, according to, Anders Gram, vice president in Human Health & Nutrition Operations at Chr Hansen, “will ease a supply problem.”

“Yes the European economy is not the strongest and there are the regulatory pressures with health claims but we have been at full capacity in this side of our business for some time and currently buy in 3% of the cultures we need from contract manufacturers,” he said.

“This is a major investment and we are glad to have made it in Europe.”

Gram would reveal no details about capacity volume or percentage increase but said it would not outsource any excess capacity.

In a statement, Henrik Dalboege, executive VP in the human health and nutrition division, added: “We started the construction work on the new freeze-drying plant just before Christmas and I am very pleased to see this project progressing as planned. It is an important element in sustaining the current and future growth of the Human Health & Nutrition Division and its contribution to the entire group.”

Market data

Euromonitor International estimates the overall global market will add about a third to hit €33.5bn in 2017, from €22bn in 2012.

The analyst predicts a slight dip in European sales in that period – from €5.13bn last year to about €5bn in 2017 – with North America, invigorated by the rise of Greek and functional yoghurt player Chobani, joining the likes of China, Brazil, Argentina, South Korea and Japan in recording double digit growth.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars